These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2865479)

  • 1. Oral anticoagulants after calf-vein thrombosis.
    Huisman MV; ten Cate JW; Büller HR
    Lancet; 1985 Nov; 2(8462):1011. PubMed ID: 2865479
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.
    Wray R; Maurer B; Shillingford J
    N Engl J Med; 1973 Apr; 288(16):815-7. PubMed ID: 4571525
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Prevention of postoperative deep venous thrombosis.
    Sixma JJ
    Neth J Med; 1973; 16(6):249-53. PubMed ID: 4767764
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of oral anticoagulant therapy after proximal deep vein thrombosis: a decision analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 1994 Mar; 71(3):286-91. PubMed ID: 8029791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of long term oral anticoagulation treatment in preventing venous thrombosis in hereditary protein S deficiency.
    Michiels JJ; Stibbe J; Bertina R; Broekmans A
    Br Med J (Clin Res Ed); 1987 Sep; 295(6599):641-3. PubMed ID: 2959350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral anticoagulants, dextran or low-dose subcutaneous heparin: which drug should be used for prevention of deep venous thrombosis in patients undergoing surgery?].
    Verstraete M
    Clin Ter; 1977 May; 81(4):291-7. PubMed ID: 880783
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):21-37. PubMed ID: 3515557
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct oral anticoagulants for superficial-vein thrombosis.
    Ageno W; Dentali F
    Lancet Haematol; 2017 Mar; 4(3):e95-e96. PubMed ID: 28215406
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of venous thromboembolism.
    Lancet; 1988 Feb; 1(8580):275-7. PubMed ID: 2893086
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Therapeutic range" for oral anticoagulant therapy.
    Hirsh J; Deykin D; Poller L
    Chest; 1986 Feb; 89(2 Suppl):11S-15S. PubMed ID: 3510825
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral anticoagulant treatment: is mild beautiful?
    Lechner K
    Ann Hematol; 1992 Feb; 64(2):51. PubMed ID: 1554794
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 15. What are the most reliable detection methods for deep vein thrombosis and pulmonary embolism to be used as endpoints in trials of venous thromboprophylaxis?
    Davidson BL
    Haemostasis; 1998; 28 Suppl 3():113-9. PubMed ID: 10069772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism].
    Hamerschlak N; Rosenfeld LG
    Arq Bras Cardiol; 1996 Sep; 67(3):209-13. PubMed ID: 9181717
    [No Abstract]   [Full Text] [Related]  

  • 17. [New possibilities for the prophylaxis of postoperative acute deep thrombophlebitis].
    Duckert F
    Vasa; 1974; 3(4):450-7. PubMed ID: 4613053
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic ranges in anticoagulant administration.
    Poller L
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1683-6. PubMed ID: 3924215
    [No Abstract]   [Full Text] [Related]  

  • 19. Are symptomatic endpoints acceptable in venous thromboprophylactic studies?
    Prentice CR
    Haemostasis; 1998; 28 Suppl 3():109-12. PubMed ID: 10069771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Haematologica; 2005 May; 90(5):713-5. PubMed ID: 15921399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.